Inhance 3D Velocity depicts colorcodedarterial and venous flow inbrain without administration ofcontrast media.
Inhance 3D Velocity depicts colorcoded arterial and venous flow in brain without administration of contrast media. Phase-contrast sequence, optimized to run on GE Healthcare’s high-end 3T Discovery MR750 and 1.5T Discovery MR450, is especially suited for use in patients who may be susceptible to gadolinium- linked nephrogenic systemic fibrosis. (Provided by GE Healthcare)
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.